As Tough COVID-19 Summer Ends, Experts Warn of Tougher Fall, Winter
A cold-weather surge of COVID-19 cases could trigger a much-feared 'second wave' of infections and deaths
Anticholinergic Meds May Raise Risk for Cognitive Decline
Effects significantly worse among individuals with risk factors for Alzheimer disease
Some Lupus Erythematosus Cases Tied to Drug Exposure
Cases found for both cutaneous and systemic lupus, but some previous reports due to protopathic bias
Chief of U.S. Vaccine Initiative Says October Timeline ‘Extremely Unlikely’
Slaoui says there is 'no intent' to introduce a COVID-19 vaccine before clinical trials are completed
Likely Deficient Vitamin D Status Linked to COVID-19 Risk
Risk for testing positive for COVID-19 increased for likely deficient versus likely sufficient vitamin D groups
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
2009 to 2019 Saw Increase in Exposure to Phenibut in U.S.
Exposure resulted in moderate effects in 49.6 percent of cases and major effects in 12.6 percent
ESC Updates Guidelines for Adult Congenital Heart Disease
Patients with congenital heart disease increasingly present as older adults, including the elderly
Child Cancer Survivors’ Hearing Loss Linked to Cognitive Deficits
Findings seen in survivors of childhood cancer independent of the neurotoxic treatment received
CDC: 13.2 Percent of U.S. Adults Used Antidepressants in 2015 to 2018
Use was higher for women than men; use highest among women aged 60 years and older